• DOI:10.1007/BF03256837
Corpus ID: 43505621

Drug-Diagnostic Co-Development in Cancer

@article{Winther2012DrugDiagnosticCI,
  title={Drug-Diagnostic Co-Development in Cancer},
  author={Henrik Winther and J. J{\o}rgensen},
  journal={Pharmaceutical Medicine},
  year={2012},
  volume={24},
  pages={363-375}
}

Henrik Winther, J. Jørgensen

Published 2012

Medicine

Pharmaceutical Medicine

Within oncology, companion diagnostics are considered to be of important value as the efficacy rates of anticancer pharmacotherapy in many cases remain low. Both the costs and the consequences of treatment failure are significant. Drug-diagnostic combinations have been known for several decades within oncology and the preselection of patients based on the differences in their biology was practiced as early as the 1970s. In relation to the development of the first companion diagnostic (for the… CONTINUE READING

View on Springer

Save to Library

Create Alert

Cite

Launch Research Feed